<DOC>
	<DOCNO>NCT01276457</DOCNO>
	<brief_summary>The purpose study allow continuation everolimus treatment patient complete core study ( NCT00170885 ) collect long-term safety , tolerability , efficacy data group patient treat upper everolimus target level plus low dose cyclosporin comparison standard everolimus target level plus low dose cyclosporin patient renal transplantation .</brief_summary>
	<brief_title>Everolimus Combination With Cyclosporine Microemulsion de Novo Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Patients function graft complete 6month treatment period core study Patients receive treatment either everolimus cyclosporin end core study Patients sign informed consent present study extension Women pregnant , lactate wish become pregnant . Other protocoldefined inclusion/exclusion criterion apply study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>immunosuppression</keyword>
	<keyword>kidney transplantation</keyword>
	<keyword>everolimus</keyword>
	<keyword>safety</keyword>
</DOC>